Kathleen Geisse, et al v. Bayer Corporation, et al
| MCKESSON CORPORATION, MERRY X-RAY CHEMICAL CORPORATION and BAYER PHARMA AG, FKA Bayer Schering Pharma AG |
| KATHLEEN GEISSE, Ph. D., CURTIS ULLESEIT and LISA WEHLMANN |
| BAYER CORPORATION, BAYER HEALTHCARE, LLC and BAYER HEALTHCARE PHARMACEUTICALS INC. |
| 19-15778 |
| April 17, 2019 |
| U.S. Court of Appeals, Ninth Circuit |
| Other |
Opinions
We have the following opinions for this case:
| Description |
|---|
| CURTIS ULLESEIT V. BAYER CORP. |
| CURTIS ULLESEIT V. BAYER CORP. |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 6, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 Filed clerk order (Deputy Clerk: SZ): The joint motion to consolidate these appeals (Docket Entry No. [ # 7 ] in No. 19-15778) is granted. Appeal Nos. 19-15778, 19-15781, 19-15782, 19-15783, and 19-15784 are consolidated. The request to designate No. 19-15783 as lead case (contained within Docket Entry No. [ # 7 ] in No. 19-15778) is denied. The consolidated opening brief and excerpts of record are due July 25, 2019; the consolidated answering brief is due August 26, 2019; and the optional consolidated reply brief is due within 21 days after service of the answering brief. In addition to any other issues that the parties wish to raise, the parties shall address the basis of this courts jurisdiction over the consolidated appeals in their briefing. See 28 U.S.C. 1447(d). [11321974] [19-15778, 19-15781, 19-15782, 19-15783, 19-15784] (JPD) [Entered: 06/06/2019 11:49 AM] |
| Filing 10 MEDIATION ORDER FILED: These cases are RELEASED from the Mediation Program. Counsel are requested to contact the Circuit Mediator should circumstances develop that warrant further settlement discussions. [11307958] [19-15778, 19-15781, 19-15782, 19-15783, 19-15784] (CL) [Entered: 05/23/2019 04:05 PM] |
| Filing 9 Filed (ECF) Appellants Bayer Corporation, Bayer Healthcare Pharmaceuticals Inc. and Bayer Healthcare, LLC Correspondence: Letter to Clerk re Circuit Rule 10-3.1(c) Notice. Date of service: 05/16/2019 [11300783] [19-15778] (Hudson, Rodney) [Entered: 05/16/2019 05:38 PM] |
| Filing 8 Added attorney Edward Dumoulin for Bayer Healthcare, LLC, Bayer Healthcare Pharmaceuticals Inc. and Bayer Corporation, in case 19-15778. [11295384] (QDL) [Entered: 05/13/2019 02:21 PM] |
| Filing 7 Filed (ECF) Appellants Bayer Corporation, Bayer Healthcare Pharmaceuticals Inc. and Bayer Healthcare, LLC Joint Motion to consolidate cases 19:15783, 19-15778, 19-15781, 19-15782 and 19-15784. Date of service: 05/13/2019. [11295346] [19-15778] (Greenblatt, Jennifer) [Entered: 05/13/2019 02:10 PM] |
| Filing 6 Filed (ECF) notice of appearance of Edward Dumoulin for Appellants Bayer Corporation, Bayer Healthcare Pharmaceuticals Inc. and Bayer Healthcare, LLC. Date of service: 05/13/2019. (Party previously proceeding without counsel: No) [11295271] [19-15778] (Dumoulin, Edward) [Entered: 05/13/2019 01:50 PM] |
| Filing 5 MEDIATION ORDER FILED: The Mediation Program of the 9th Circuit Court of Appeals facilitates settlement while appeals are pending. By 05/22/2019, counsel for all parties intending to file briefs in this matter are requested to inform the Circuit Mediator by email of their clients' views on whether the issues on appeal or the underlying dispute might be amenable to settlement presently or in the foreseeable future. This communication will be kept confidential, if requested... This communication should not be filed with the court... The existing briefing schedules remains in effect... [11290588] [19-15778, 19-15781, 19-15782, 19-15783, 19-15784] (CL) [Entered: 05/08/2019 11:24 AM] |
| Filing 4 Filed (ECF) Appellees Kathleen Geisse, Ph. D., Curtis Ulleseit and Lisa Wehlmann Mediation Questionnaire. Date of service: 04/24/2019. [11276377] [19-15778] (Cutter, Curtis) [Entered: 04/24/2019 06:59 PM] |
| Filing 3 The Mediation Questionnaire for this case was filed on 04/24/2019. To submit pertinent confidential information directly to the Circuit Mediators, please use the following # link . Confidential submissions may include any information relevant to mediation of the case and settlement potential, including, but not limited to, settlement history, ongoing or potential settlement discussions, non-litigated party related issues, other pending actions, and timing considerations that may impact mediation efforts.[11276373] (AD) [Entered: 04/24/2019 06:44 PM] |
| Filing 2 Filed (ECF) Appellants Bayer Corporation, Bayer Healthcare Pharmaceuticals Inc. and Bayer Healthcare, LLC Mediation Questionnaire. Date of service: 04/24/2019. [11275691] [19-15778] (Greenblatt, Jennifer) [Entered: 04/24/2019 02:00 PM] |
| Filing 1 DOCKETED CAUSE AND ENTERED APPEARANCES OF COUNSEL. SEND MQ: Yes. The schedule is set as follows: Mediation Questionnaire due on 04/24/2019. Transcript ordered by 05/16/2019. Transcript due 06/17/2019. Appellants Bayer Corporation, Bayer Healthcare Pharmaceuticals Inc. and Bayer Healthcare, LLC opening brief due 07/25/2019. Appellees Kathleen Geisse, Curtis Ulleseit and Lisa Wehlmann answering brief due 08/26/2019. Appellant's optional reply brief is due 21 days after service of the answering brief. [11267279] (JBS) [Entered: 04/17/2019 01:51 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
